Nutrien (NTR) 6-K Nutrien Reports Fourth Quarter and Full-Year 2023 Results

Exhibit 99.1

	News Release
NYSE, TSX: NTR

February 21, 2024 – all amounts are in US dollars except as otherwise noted

Nutrien Reports Fourth Quarter and Full-Year 2023 Results

Fourth quarter results reflect strong fertilizer market fundamentals in North America. Expect increased

fertilizer sales volumes and growth in Retail earnings in 2024.

SASKATOON, Saskatchewan - Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2023 results, with net earnings of $176 million ($0.35 diluted net earnings per share). Fourth quarter 2023 adjusted net earnings per share¹ was $0.37 and adjusted EBITDA¹ was $1.1 billion.

“We saw a continuation of strong fertilizer market fundamentals in North America during the fourth quarter driven by improved affordability, an extended fall application season and low channel inventories. Utilizing the strengths of our integrated business, we achieved record fourth-quarter potash deliveries, increased crop nutrient sales volumes across our global Retail network and generated strong cash flow from operations,” commented Ken Seitz, Nutrien’s President and CEO.

“As we look ahead to 2024, we expect to deliver higher fertilizer sales volumes and Retail earnings, supported by increased crop input market stability and demand. We continue to prioritize strategic initiatives that enhance our capability to serve growers in our core markets, maintain the low-cost position and reliability of our assets, and position the Company for growth,” added Mr. Seitz.

Highlights²:

• Generated net earnings of $1.3 billion ($2.53 diluted net earnings per share) and adjusted EBITDA¹ of $6.1 billion ($4.44 adjusted net earnings per share¹) in 2023, down from the record levels achieved in 2022. Adjusted EBITDA declined primarily due to lower net realized selling prices across all segments and lower Nutrien Ag Solutions (“Retail”) earnings. Cash provided by operating activities totaled $5.1 billion in 2023, representing 84 percent of adjusted EBITDA.

• Retail adjusted EBITDA of $1.5 billion in 2023 decreased primarily due to lower gross margin for both crop nutrients and crop protection products, as we sold through high-cost inventory. Crop nutrient sales volumes increased as growers returned to more normalized application rates to replenish nutrients in the soil. We continued to grow our proprietary nutritional and biostimulant sales and margins through differentiated product offerings and expanded manufacturing capacity.

• Potash full year 2023 adjusted EBITDA declined to $2.4 billion due to lower net realized selling prices. We delivered record fourth quarter potash sales volumes driven by strong demand in North America and increased offshore sales.

• Nitrogen full year 2023 adjusted EBITDA decreased to $1.9 billion due to lower net realized selling prices for all major nitrogen products, which more than offset lower natural gas costs and higher sales volumes.

• In the fourth quarter of 2023, we recognized a $76 million non-cash impairment in our Nitrogen segment relating to our Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability. We expect improved natural gas availability in Trinidad as the development of additional gas fields is anticipated to add new supply starting in 2026.

• Returned $2.1 billion to shareholders in 2023 through dividends and share repurchases. Nutrien’s Board of Directors approved an increase in the quarterly dividend to $0.54 per share. Nutrien continues to target a stable and growing dividend with our dividend per share increasing by 35 percent since the beginning of 2018. Nutrien’s Board of Directors also approved the purchase of up to 5 percent of Nutrien’s outstanding common shares over a twelve-month period through a normal course issuer bid (“NCIB”). The NCIB is subject to acceptance by the Toronto Stock Exchange.

1. These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section for further information.

2. Our discussion of highlights set out on this page is a comparison of the results for the twelve months ended December 31, 2023 to the results for the twelve months ended December 31, 2022, unless otherwise noted.

1

Market Outlook and Guidance

Agriculture and Retail

• Global grain stocks-to-use ratios remain historically low going into the 2024 growing season as tightening supplies of wheat and rice have offset increased corn supplies in the US and Brazil. We expect weather and geopolitical issues will continue to impact grain and oilseed production, exports and inventory levels.

• Crop prices have declined from historically high levels in 2022, but lower crop input prices have resulted in improved demand, evidenced by the strong North American fall application season in 2023. We expect US corn plantings to range from 91 to 92 million acres in 2024 and soybean plantings to range from 87 to 88 million acres.

• In Brazil, dry weather during the summer crop growing season and lower corn prices could result in lower corn area in 2024. Brazilian growers are expected to continue to expand soybean acreage, which we anticipate will support the need for strong fertilizer imports in the second and third quarters of 2024.

• In Australia, growers have benefited from multiple years of above-average yields and fundamentals remain supportive entering 2024. Timely precipitation led to higher-than-expected winter crop production, however if the El Niño weather pattern continues, it could pose a risk for the 2024 growing season.

Crop Nutrient Markets

• Global potash demand was strong through the second half of 2023, and we estimate full-year shipments were between 67 to 68 million tonnes. The increase was supported by strong consumption and increased imports in key markets such as North America, China and Brazil.

• We expect global potash demand will continue to recover towards trend levels in 2024 with full-year shipments projected between 68 to 71 million tonnes. We anticipate a relatively balanced global market with incremental supply from producers in Canada, Russia, Belarus and Laos.

• We are seeing strong potash demand ahead of the North American spring application season as channel inventories were tight to start the year. Potash demand in Southeast Asia is expected to increase significantly in 2024 due to much lower inventory levels compared to the prior year and favorable economics for key crops such as oil palm and rice. We expect lower potash imports from China compared to the record levels in 2023 but for demand to remain at historically high levels driven by increased consumption.

• We expect nitrogen supply constraints to persist in 2024, including limited Russian ammonia exports, reduced European operating rates and Chinese urea export restrictions. North American natural gas prices remain highly competitive compared to Europe and Asia, and we expect Henry Hub natural gas prices to average approximately $2.50 per MMBtu for the year.

• The US nitrogen supply and demand balance is projected to be tight ahead of the spring application season, as nitrogen fertilizer net imports in the first half of the 2023/2024 fertilizer year were down an estimated 55 percent compared to the three-year average. Global industrial nitrogen demand remains a risk in 2024 as industrial production, most notably in Europe and Asia, has yet to rebound to historical levels.

• Phosphate fertilizer markets have remained relatively strong in the first quarter of 2024, particularly in North America where channel inventories were low entering the year. We expect Chinese phosphate exports to be similar to 2023 levels and tight stocks in India to support demand ahead of their key planting season.

Financial Guidance

We have revised our guidance practice in 2024 to provide forward looking estimates on those metrics that we believe are of value to our shareholders and are less impacted by fertilizer commodity prices. We continue to provide guidance for Retail adjusted EBITDA, fertilizer sales volumes and other key financial modeling metrics as well as fertilizer pricing sensitivities.

• Retail adjusted EBITDA guidance of $1.65 to $1.85 billion assumes increased gross margins in all major product lines compared to 2023. We anticipate that crop nutrient gross margin will be supported by higher sales volumes and per-tonne margins, in particular compared to the compressed levels in the first half of the prior year. We expect a recovery in Brazilian crop protection margins in the second half of 2024.

2

• Potash sales volume guidance of 13.0 to 13.8 million tonnes assumes demand growth in offshore markets and a return to more normal Canpotex port operations in 2024. In North America, we expect increased first quarter sales volumes compared to the prior year due to strong customer engagement to refill depleted inventories.

• Nitrogen sales volume guidance of 10.6 to 11.2 million tonnes assumes higher operating rates at our US and Trinidad plants compared to 2023. Phosphate sales volume guidance of 2.6 to 2.8 million tonnes assumes improved operating rates compared to the prior year.

• Total capital expenditures of $2.2 to $2.3 billion are expected to be below the prior year. This total includes approximately $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, mine automation projects in Potash, and low-cost brownfield expansions in Nitrogen.

All guidance numbers, including those noted above are outlined in the table below. In addition, set forth below are anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

	2024 Guidance Ranges 1 as of February 21, 2024
(billions of US dollars, except as otherwise noted)	Low		High		2023 Actual
Retail adjusted EBITDA		1.65		1.85		1.5
Potash sales volumes (million tonnes) 2		13.0		13.8		13.2
Nitrogen sales volumes (million tonnes) 2		10.6		11.2		10.4
Phosphate sales volumes (million tonnes) 2		2.6		2.8		2.6
Depreciation and amortization		2.2		2.3		2.2
Finance costs		0.75		0.85		0.8
Effective tax rate on adjusted earnings (%)		24.0		26.0		28.0
Capital expenditures 3		2.2		2.3		2.7

 1 See the “Forward-Looking Statements” section.

 2 Manufactured product only.

 3 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures which are supplementary financial measures. See the “Other Financial Measures” section.

2024 Annual Sensitivities 1	Effect on
(millions of US dollars, except EPS amounts)		Adjusted EBITDA		Adjusted EPS	4
$25/tonne change in net realized potash selling prices		±270		±0.40
$25/tonne change in net realized ammonia selling prices 2		± 40		±0.05
$25/tonne change in net realized urea and ESN® selling prices		±  80		±0.10
$25/tonne change in net realized solutions, nitrates and sulfates selling prices		±130		±0.20
$1/MMBtu change in NYMEX natural gas price 3		±190		±0.30

 1 See the “Forward-Looking Statements” section.

 2 Includes related impact on natural gas costs in Trinidad, which is linked to benchmark ammonia pricing.

 3 Nitrogen related impact.

 4 Assumes 496 million shares outstanding for all earnings per share (“EPS”) sensitivities.

3

Consolidated Results

	Three Months Ended December 31							Twelve Months Ended December 31
(millions of US dollars, except as otherwise noted)		2023		2022		% Change			2023		2022		% Change
Sales		5,664		7,533		(25	)		29,056		37,884		(23	)
Freight, transportation and distribution		260		244		7			974		872		12
Cost of goods sold		3,636		4,383		(17	)		19,608		21,588		(9	)
Gross margin		1,768		2,906		(39	)		8,474		15,424		(45	)
Expenses		1,475		1,247		18			5,729		4,615		24
Net earnings		176		1,118		(84	)		1,282		7,687		(83	)
Adjusted EBITDA 1		1,075		2,095		(49	)		6,058		12,170		(50	)
Diluted net earnings per share		0.35		2.15		(84	)		2.53		14.18		(82	)
Adjusted net earnings per share 1		0.37		2.02		(82	)		4.44		13.19		(66	)
Cash provided by operating activities		4,150		4,736		(12	)		5,066		8,110		(38	)
Cash used in investing activities		(733	)	(1,222	)	(40	)		(2,958	)	(2,901	)	2
Cash used for dividends and share repurchases 2		(262	)	(1,465	)	(82	)		(2,079	)	(5,551	)	(63	)

 1  These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

 2  This is a supplementary financial measure. See the “Other Financial Measures” section.

Net earnings and adjusted EBITDA decreased in the fourth quarter and full year of 2023 compared to the same periods in 2022, mainly due to lower net realized selling prices across all segments and lower Retail earnings. This was partially offset by decreased cost of goods sold from lower natural gas and royalty costs, lower provincial mining taxes, higher sales volumes for Retail crop nutrients and increased Potash and Nitrogen sales volumes. For the full year of 2023, we recorded non-cash impairment of assets of $774 million in aggregate primarily related to Retail – South America goodwill and Nitrogen and Phosphate property, plant and equipment, resulting in lower net earnings. For the full year of 2022, we recorded a non-cash impairment reversal of an aggregate of $780 million related to our Phosphate assets. The decrease in cash provided by operating activities in the fourth quarter and full-year 2023 compared to the same periods in 2022 was primarily due to lower earnings across all segments.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2023 to the results for the three and twelve months ended December 31, 2022, unless otherwise noted.

 Nutrien Ag Solutions (“Retail”)

	Three Months Ended December 31
(millions of US dollars, except	Dollars									Gross Margin									Gross Margin (%)
as otherwise noted)	2023			2022			% Change			2023			2022			% Change			2023		2022
Sales
Crop nutrients		1,808			2,320			(22	)		346			349			(1	)		19		15
Crop protection products		960			981			(2	)		333			413			(19	)		35		42
Seed		202			251			(20	)		36			46			(22	)		18		18
Merchandise		251			264			(5	)		41			41			-			16		16
Nutrien Financial		70			62			13			70			62			13			100		100
Services and other		236			237			-			188			194			(3	)		80		82
Nutrien Financial elimination 1		(25	)		(28	)		(11	)		(25	)		(28	)		(11	)		100		100
		3,502			4,087			(14	)		989			1,077			(8	)		28		26
Cost of goods sold		2,513			3,010			(17	)
Gross margin		989			1,077			(8	)
Expenses ²		973			888			10
Earnings before finance costs and taxes (“EBIT”)		16			189			(92	)
Depreciation and amortization		201			202			-
EBITDA		217			391			(45	)
Adjustments 3		12			-			n/m
Adjusted EBITDA		229			391			(41	)

 1  Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

 2  Includes selling expenses of $841 million (2022 – $836 million).

 3  See Note 2 to the unaudited condensed consolidated financial statements.

4

	Twelve Months Ended December 31
(millions of US dollars, except	Dollars									Gross Margin									Gross Margin (%)
as otherwise noted)	2023			2022			% Change			2023			2022			% Change			2023		2022
Sales
Crop nutrients		8,379			10,060			(17	)		1,378			1,766			(22	)		16		18
Crop protection products		6,750			7,067			(4	)		1,553			1,936			(20	)		23		27
Seed		2,295			2,112			9			427			428			-			19		20
Merchandise		1,001			1,019			(2	)		172			174			(1	)		17		17
Nutrien Financial		322			267			21			322			267			21			100		100
Services and other		927			966			(4	)		710			749			(5	)		77		78
Nutrien Financial elimination		(132	)		(141	)		(6	)		(132	)		(141	)		(6	)		100		100
		19,542			21,350			(8	)		4,430			5,179			(14	)		23		24
Cost of goods sold		15,112			16,171			(7	)
Gross margin		4,430			5,179			(14	)
Expenses ¹,²		4,215			3,621			16
EBIT		215			1,558			(86	)
Depreciation and amortization		759			752			1
EBITDA		974			2,310			(58	)
Adjustments 2		485			(17	)		n/m
Adjusted EBITDA		1,459			2,293			(36	)

 1  Includes selling expenses of $3,375 million (2022 – $3,392 million).

 2  Includes non-cash impairment of assets of $465 million (2022 – nil). See Notes 2 and 3 to the unaudited condensed consolidated financial statements.

• Retail adjusted EBITDA decreased in the fourth quarter of 2023 primarily due to lower gross margin for crop protection products and higher expenses. For the full year, adjusted EBITDA was lower mostly due to lower gross margin for both crop nutrients and crop protection products. Included within expenses for the full year of 2023, we recognized a $465 million non-cash impairment primarily related to goodwill of our South American Retail assets. The impairment was mainly due to the impact of crop input price volatility, more moderate long-term growth assumptions and higher interest rates.

• Crop nutrients sales and gross margin decreased in the fourth quarter and full year of 2023 due to lower selling prices across all regions compared to the strong comparable periods in 2022. Sales volumes increased for both the fourth quarter and full year as growers returned to more normalized application rates to replenish nutrients in the soil. Full year sales and gross margin of our proprietary nutritional and biostimulant product lines increased compared to 2022 levels as we continued to expand our differentiated product offering and manufacturing capacity.

• Crop protection products sales and gross margin were lower in the fourth quarter and full year of 2023 primarily due to decreased selling prices compared to the historically strong comparable periods in 2022. This was partially offset by higher fourth quarter sales in North America as growers returned to more normalized buying behaviors. Gross margin in 2023 was also impacted by the selling through of high-cost inventory, which in the fourth quarter was primarily related to South America.

• Seed sales and gross margin decreased in the fourth quarter of 2023 due to lower soybean sales volumes and competitive market prices in South America. Full-year sales increased primarily due to increased corn sales in the US, while gross margin saw little change compared to the prior year.

• Nutrien Financial sales increased in the fourth quarter and full year of 2023 due to higher utilization of our financing offerings in the US and Australia compared to the same periods in 2022.

5

 Potash

	Three Months Ended December 31
(millions of US dollars, except	Dollars							Tonnes (thousands)					Average per Tonne
as otherwise noted)	2023		2022		% Change			2023	2022		% Change		2023		2022		% Change
Manufactured product
Net sales
North America		372		536		(31	)	1,089		959		14		342		560		(39	)
Offshore		404		841		(52	)	2,214		1,659		33		182		506		(64	)
		776		1,377		(44	)	3,303		2,618		26		235		526		(55	)
Cost of goods sold		349		310		13								106		118		(10	)
Gross margin – total		427		1,067		(60	)							129		408		(68	)
Expenses ¹		82		198		(59	)	Depreciation and amortization						36		34		6
EBIT		345		869		(60	)	Gross margin excluding depreciation
Depreciation and amortization		118		89		33		and amortization – manufactured 2						165		442		(63)
EBITDA / Adjusted EBITDA		463		958		(52	)	Potash controllable cash cost of
								product manufactured 2						56		65		(14	)

 1  Includes provincial mining taxes of $79 million (2022 – $190 million).

 2  These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

	Twelve Months Ended December 31
(millions of US dollars, except	Dollars							Tonnes (thousands)						Average per Tonne
as otherwise noted)	2023		2022		% Change			2023	2022		% Change			2023		2022		% Change
Manufactured product
Net sales
North America		1,683		2,485		(32	)	4,843		3,729		30			348		667		(48	)
Offshore		2,076		5,414		(62	)	8,373		8,808		(5	)		248		615		(60	)
		3,759		7,899		(52	)	13,216		12,537		5			284		630		(55	)
Cost of goods sold		1,396		1,400		-									105		112		(6	)
Gross margin – total		2,363		6,499		(64	)								179		518		(65	)
Expenses ¹		422		1,173		(64	)	Depreciation and amortization							35		35		-
EBIT		1,941		5,326		(64	)	Gross margin excluding depreciation
Depreciation and amortization		463		443		5		and amortization – manufactured							214		553		(61	)
EBITDA / Adjusted EBITDA		2,404		5,769		(58	)	Potash controllable cash cost of
								product manufactured							58		58		-

 1  Includes provincial mining taxes of $398 million (2022 – $1,149 million).

• Potash adjusted EBITDA declined in the fourth quarter and full year of 2023 due to lower net realized selling prices, which more than offset higher North American sales volumes and lower provincial mining taxes and royalties. We increased granular potash production in the fourth quarter to meet customer demand and reduced our controllable cash cost of product manufactured to $56 per tonne.

• Sales volumes in North America were higher in the fourth quarter and full year of 2023 due to lower channel inventory and increased grower demand supported by an extended fall application window and improved affordability. Offshore sales volumes were higher in the fourth quarter compared to the same period in the prior year driven by stronger demand in Brazil and China. Full-year offshore sales volumes were lower compared to the record levels in 2022 primarily due to logistical challenges at Canpotex’s West Coast port facilities and reduced shipments to customers in India and Southeast Asia.

• Net realized selling price decreased in the fourth quarter and full year of 2023 compared to the historically strong periods in 2022, due to a decline in benchmark prices and higher costs related to logistical challenges at Canpotex’s West Coast port facilities.

• Cost of goods sold per tonne decreased in the fourth quarter and full year of 2023 mainly due to lower royalties. Fourth quarter costs were also lower due to the timing of turnaround activity.

6

Canpotex Sales by Market

(percentage of sales volumes, except as		Three Months Ended December 31							Twelve Months Ended December 31
otherwise noted)	2023		2022		Change			2023		2022		Change
Latin America		32		28		4			47		34		13
Other Asian markets 1		28		35		(7	)		28		34		(6	)
Other markets		10		10		-			11		10		1
China		19		16		3			9		14		(5	)
India		11		11		-			5		8		(3	)
		100		100					100		100

 1  All Asian markets except China and India.

 Nitrogen

	Three Months Ended December 31
(millions of US dollars, except	Dollars							Tonnes (thousands)						Average per Tonne
as otherwise noted)	2023		2022		% Change			2023	2022		% Change			2023		2022		% Change
Manufactured product
Net sales
Ammonia		271		689		(61	)	651		776		(16	)		416		887		(53	)
Urea and ESN® 1		316		510		(38	)	739		764		(3	)		428		666		(36	)
Solutions, nitrates and  sulfates		290		389		(25	)	1,344		1,056		27			215		368		(42	)
		877		1,588		(45	)	2,734		2,596		5			321		611		(47	)
Cost of goods sold 1		595		892		(33	)								218		343		(36	)
Gross margin – manufactured		282		696		(59	)								103		268		(62	)
Gross margin – other 1,2		3		3		-		Depreciation and amortization 1							53		60		(12	)
Gross margin – total		285		699		(59	)	Gross margin excluding depreciation
Expenses 3,4		116		13		792		and amortization – manufactured 5							156		328		(52	)
EBIT		169		686		(75	)	Ammonia controllable cash cost of
Depreciation and amortization		146		155		(6	)	product manufactured 5							59		57		4
EBITDA		315		841		(63	)
Adjustments 4		76		-		n/m
Adjusted EBITDA		391		841		(54	)

1 Certain immaterial 2022 figures have been reclassified.

2 Includes other nitrogen and purchased products and comprises net sales of $79 million (2022 – $204 million) less cost of goods sold of $76 million (2022 – $201 million).

3 Includes (loss) earnings from equity-accounted investees of $(1) million (2022 – $41 million).

4 Includes a non-cash impairment of assets of $76 million (2022 – nil). See Notes 2 and 3 to the unaudited condensed consolidated financial statements.

5 These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

7

	Twelve Months Ended December 31
(millions of US dollars, except	Dollars									Tonnes (thousands)						Average per Tonne
as otherwise noted)	2023			2022			% Change			2023	2022		% Change			2023		2022		% Change
Manufactured product
Net sales
Ammonia		1,144			2,641			(57	)	2,436		2,715		(10	)		469		973		(52	)
Urea and ESN® 1		1,499			2,134			(30	)	3,125		3,014		4			480		708		(32	)
Solutions, nitrates and  sulfates		1,187			1,829			(35	)	4,862		4,551		7			244		402		(39	)
		3,830			6,604			(42	)	10,423		10,280		1			367		642		(43	)
Cost of goods sold 1		2,435			3,370			(28	)								233		327		(29	)
Gross margin – manufactured		1,395			3,234			(57	)								134		315		(57	)
Gross margin – other 1,2		(16	)		47			n/m		Depreciation and amortization							55		54		2
Gross margin – total		1,379			3,281			(58	)	Gross margin excluding depreciation
Expenses (income) 3,4		97			(92	)		n/m		and amortization – manufactured							189		369		(49	)
EBIT		1,282			3,373			(62	)	Ammonia controllable cash cost of
Depreciation and amortization		572			558			3		product manufactured							60		59		2
EBITDA		1,854			3,931			(53	)
Adjustments 4		76			-			n/m
Adjusted EBITDA		1,930			3,931			(51	)

1 Certain immaterial 2022 figures have been reclassified.

2 Includes other nitrogen and purchased products and comprises net sales of $377 million (2022 – $929 million) less cost of goods sold of $393 million (2022 – $882 million).

3 Includes earnings from equity-accounted investees of $90 million (2022 – $233 million).

4 Includes a non-cash impairment of assets of $76 million (2022 – nil). See Notes 2 and 3 to the unaudited condensed consolidated financial statements.

• Nitrogen adjusted EBITDA was lower in the fourth quarter and full year of 2023 due to lower net realized selling prices for all major nitrogen products, which more than offset lower natural gas costs and higher sales volumes. Our fourth quarter ammonia operating rate increased to 91 percent¹ compared to 83 percent in the same period in 2022 primarily due to improved reliability and the absence of major weather-related unplanned outages. We recognized a $76 million non-cash impairment of our Trinidad property, plant and equipment during the fourth quarter due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability. We expect improved natural gas availability in Trinidad as the development of additional gas fields is anticipated to add new supply starting in 2026.

• Sales volumes were higher in the fourth quarter and full year of 2023 primarily due to higher UAN production and sales, partially offset by lower ammonia availability mainly due to production outages at our plants in Trinidad.

• Net realized selling price was lower in the fourth quarter and full year of 2023 for all major nitrogen products primarily due to weaker benchmark prices resulting from lower energy prices in key nitrogen producing regions.

• Cost of goods sold per tonne decreased in the fourth quarter and full year of 2023 due to lower natural gas costs. Ammonia controllable cash cost of product manufactured per tonne increased in 2023 mainly due to the impact of lower ammonia production.

Natural Gas Prices in Cost of Production

	Three Months Ended December 31									Twelve Months Ended December 31
(US dollars per MMBtu, except as otherwise noted)	2023			2022			% Change			2023			2022			% Change
Overall natural gas cost excluding realized derivative impact		3.35			7.49			(55	)		3.51			7.82			(55	)
Realized derivative impact		(0.05	)		(0.05	)		-			(0.02	)		(0.05	)		(60	)
Overall natural gas cost		3.30			7.44			(56	)		3.49			7.77			(55	)
Average NYMEX		2.88			6.26			(54	)		2.74			6.64			(59	)
Average AECO		1.94			4.11			(53	)		2.17			4.28			(49	)

• Natural gas prices in our cost of production decreased in the fourth quarter and full year of 2023 as a result of lower North American natural gas index prices and decreased natural gas costs in Trinidad, where our natural gas prices are linked to ammonia benchmark prices.

1 Excludes Trinidad and Joffre.

8

 Phosphate

	Three Months Ended December 31
(millions of US dollars, except   as otherwise noted)	Dollars									Tonnes (thousands)							Average per Tonne
	2023			2022			% Change			2023		2022		% Change			2023		2022		% Change
Manufactured product
Net sales
Fertilizer		322			274			18			579		391		48			557		700		(20	)
Industrial and feed		150			155			(3	)		174		140		24			860		1,107		(22	)
		472			429			10			753		531		42			627		807		(22	)
Cost of goods sold		402			405			(1	)									535		762		(30	)
Gross margin – manufactured		70			24			192										92		45		104
Gross margin – other 1		-			(8	)		(100	)		Depreciation and amortization							108		109		(1	)
Gross margin – total		70			16			338			Gross margin excluding depreciation
Expenses		21			46			(54	)		and amortization – manufactured 2							200		154		30
EBIT		49			(30	)		n/m
Depreciation and amortization		81			58			40
EBITDA / Adjusted EBITDA		130			28			364
1 Includes other phosphate and purchased products and comprises net sales of $61 million (2022 – $72 million) less cost of goods sold of $61 million (2022 – $80 million).
2 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.
	Twelve Months Ended December 31
(millions of US dollars, except   as otherwise noted)	Dollars									Tonnes (thousands)							Average per Tonne
	2023			2022			% Change			2023		2022		% Change			2023		2022		% Change
Manufactured product
Net sales
Fertilizer		1,085			1,367			(21	)		1,912		1,696		13			568		806		(30	)
Industrial and feed		645			706			(9	)		639		682		(6	)		1,010		1,035		(2	)
		1,730			2,073			(17	)		2,551		2,378		7			678		872		(22	)
Cost of goods sold		1,487			1,562			(5	)									583		657		(11	)
Gross margin – manufactured		243			511			(52	)									95		215		(56	)
Gross margin – other 1		(10	)		(18	)		(44	)		Depreciation and amortization							115		79		46
Gross margin – total		233			493			(53	)		Gross margin excluding depreciation
Expenses (income) 2		290			(693	)		n/m			and amortization – manufactured							210		294		(29	)
EBIT		(57	)		1,186			n/m
Depreciation and amortization		294			188			56
EBITDA		237			1,374			(83	)
Adjustments 2		233			(780	)		n/m
Adjusted EBITDA		470			594			(21	)

1 Includes other phosphate and purchased products and comprises net sales of $263 million (2022 – $304 million) less cost of goods sold of $273 million (2022 – $322 million).

2 Includes non-cash impairment of assets of $233 million (2022 – reversal of non-cash impairment of assets of $780 million). See Notes 2 and 3 to the unaudited condensed consolidated financial statements.

• Phosphate adjusted EBITDA increased in the fourth quarter of 2023 primarily due to lower sulfur and ammonia input costs, partially offset by lower net realized selling prices. Full-year 2023 adjusted EBITDA was lower compared to the prior year mainly due to lower net realized selling prices for fertilizer products, partially offset by lower ammonia and sulfur input costs. Included in the expenses for the full year of 2023, we recognized a $233 million non-cash impairment of our White Springs property, plant and equipment, while we had non-cash impairment reversals of our Phosphate assets of $780 million for the full year of 2022.

• Sales volumes increased in the fourth quarter and full year of 2023 mostly due to higher phosphate fertilizer demand, with the full year being partially offset by lower first-half production impacting our industrial and feed sales. Production increased in the fourth quarter and full-year 2023 largely due to improved reliability at our Aurora plant.

• Net realized selling price decreased in the fourth quarter and full year of 2023 primarily due to lower fertilizer net realized selling prices and lower industrial and feed net realized selling prices which reflect the typical lag in price realizations relative to spot fertilizer prices.

• Cost of goods sold per tonne decreased in the fourth quarter and full year of 2023 mainly due to lower ammonia and sulfur costs, partially offset by higher depreciation from reversal of non-cash impairment of assets in 2022.

9

 Corporate and Others

(millions of US dollars, except as otherwise	Three Months Ended December 31						Twelve Months Ended December 31
noted)	2023		2022		% Change		2023		2022		% Change
Selling expense (recovery)	7		5		40		-		(1	)	n/m
General and administrative expenses	104		99		5		364		326		12
Share-based compensation (recovery) expense	(7	)	(59	)	(88	)	(14	)��	63		n/m
Other expenses	161		67		140		348		227		53
EBIT	(265	)	(112	)	137		(698	)	(615	)	13
Depreciation and amortization	19		16		19		81		71		14
EBITDA	(246	)	(96	)	156		(617	)	(544	)	13
Adjustments 1	129		(84	)	n/m		350		146		140
Adjusted EBITDA	(117	)	(180	)	(35	)	(267	)	(398	)	(33	)
1 See Note 2 to the unaudited condensed consolidated financial statements.

• General and administrative expenses were higher in the full year of 2023 primarily due to higher staffing costs and higher depreciation and amortization expense.

• Share-based compensation was a recovery in the fourth quarter and full year of 2023 due to a decrease in the fair value of share-based awards outstanding relative to the comparable periods in 2022. The fair value takes into consideration several factors such as our share price movement, our performance relative to our peer group and return on our invested capital.

• Other expenses were higher in the fourth quarter and full year of 2023 compared to the same periods in 2022 due to the following:

• Higher expense for asset retirement obligations and accrued environmental costs related to our non-operating sites due to changes in closure cost estimates.

• $92 million loss on Blue Chip Swaps through trade transactions to remit cash from Argentina in the second quarter of 2023. The loss is a result of the significant divergence between the Blue Chip Swap market exchange rate and the official Argentinian Central Bank rate.

• Higher foreign exchange losses primarily from our Retail – South America region.

• The above expenses were partially offset by an $80 million gain recognized in the first quarter of 2023 from amendments due to design plan changes to our other post-retirement benefit plans.

 Eliminations

• Eliminations are not part of the Corporate and Others segment. The elimination of gross margin between operating segments was $3 million for the fourth quarter of 2023 compared to a recovery of $47 million in the same period of 2022. For the full year of 2023, there was a recovery of $69 million compared to an elimination of $28 million in the same period in 2022. These variances are due to the timing of release of intersegment inventories held by our Retail segment.

Finance Costs, Income Taxes and Other Comprehensive Income (Loss)

(millions of US dollars, except as otherwise	Three Months Ended December 31						Twelve Months Ended December 31
noted)		2023		2022	% Change			2023	2022		% Change
Finance costs		213		188	13			793	563		41
Income tax (recovery) expense		(96	)	353	n/m			670	2,559		(74	)
Actual effective tax rate including discrete items (%)		(120	)	24	n/m			34	25		9
Other comprehensive income (loss)		97		119	(18	)		81	(177	)	n/m

• Finance costs were higher in the fourth quarter and full year of 2023 compared to the same periods in 2022 primarily due to higher interest rates and higher average long-term debt balances.

• Income tax (recovery) expense was lower in the fourth quarter and full year of 2023 primarily as a result of lower earnings compared to the same periods in 2022. The full year of 2023 expense and effective tax rate reflect a $134 million income tax recovery due to changes to our tax declarations in Switzerland (“Swiss Tax Reform adjustment”) and a $101 million income tax expense due to a change in recognition of deferred tax assets in our Retail – South America region. The 2023 effective tax rates also include the impact of our losses in Retail – South America, wherein we did not recognize a corresponding deferred tax asset as it did not meet the accounting criteria for asset recognition.

10

• Other comprehensive income (loss) was primarily driven by changes in the currency translation of our Retail foreign operations primarily due to improvements of Canadian and Australian currencies relative to the US dollar for the fourth quarter and full year of 2023. For the fourth quarter and full year of 2023, we recognized actuarial gains on our defined benefit plans compared to losses on the comparative periods driven by changes in our financial and demographic assumptions and performance of our plan assets.

Forward-Looking Statements

Certain statements and other information included in this document, including within the “Market Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “project”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien’s business strategies, plans, prospects and opportunities; Nutrien’s 2024 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted earnings and capital expenditures; our projections to generate strong cash from operations; expectations regarding our capital allocation intentions and strategies; our ability to advance strategic initiatives and high value growth investments, including expectations regarding our ability to serve growers, maintain a low-cost position of fertilizer production assets and increase free cash flow; capital spending expectations for 2024 and beyond, including spending related to advancement of proprietary products, network optimization and digital capabilities in Retail, automation in Potash mining, and brownfield expansions in Nitrogen; expectations regarding our ability to generate free cash flow and return capital to our shareholders, including our expectations regarding stable and growing dividends; expectations regarding Retail inventory levels in North America; expectations regarding performance of our operating segments in 2024, including increased fertilizer sales volumes and growth in Retail earnings; our operating segment market outlooks and our expectations for market conditions and fundamentals in 2024 and beyond, and the anticipated supply and demand for our products and services, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, grower crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the expected impacts and timing of new supply from additional gas fields in Trinidad; the resulting outlook of higher expected natural gas costs and lower near-term availability from the new natural gas contract related to our Trinidad property, plant and equipment in our Nitrogen segment; the negotiation of sales contracts; timing and impacts of plant turnarounds; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders. These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty. The additional key assumptions that have been made include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies on the anticipated timeline or at all; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, including the current El Niño weather pattern, supplier agreements, availability, inventory levels, exports, crop development and cost of labor and interest, exchange and effective tax rates; assumptions with respect to global economic conditions and the accuracy of our market outlook expectations for 2024 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets, including in relation to our Retail - South America group of CGUs goodwill and intangible asset impairment and the impairment of our Nitrogen and Phosphate property, plant and equipment; assumptions with respect to the timing and benefits of additional gas fields in Trinidad; assumptions with respect to our intention to complete share repurchases under our normal course issuer bid programs, including Toronto Stock Exchange approval, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and the ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts.

11

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives or results of operations; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including the current El Niño weather pattern, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including tariffs, trade restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; political risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism; the occurrence of a major environmental or safety incident; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the Securities and Exchange Commission in the United States.

The purpose of our Retail adjusted EBITDA, sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted earnings and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms & Definitions” section of our 2022 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

12

About Nutrien

Nutrien is a leading provider of crop inputs and services, helping to safely and sustainably feed a growing world. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our integrated business and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

For Further Information:

Investor Relations:

Jeff Holzman

Vice President, Investor Relations

(306) 933-8545

Investors@nutrien.com

Media Relations:

Megan Fielding

Vice President, Brand & Culture Communications

(403) 797-3015

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, February 22, 2024 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

• From Canada and the US 1-888-886-7786

• International 1-416-764-8658

• No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/investors/events/2023-q4-earnings-conference-call

13

Appendix A – Selected Additional Financial Data

Selected Retail Measures	Three Months Ended December 31						Twelve Months Ended December 31
	2023			2022			2023		2022
Proprietary products gross margin (millions of US dollars)
Crop nutrients		44			55			391		370
Crop protection products		27			58			461		675
Seed		(3	)		(7	)		168		166
Merchandise		3			5			11		12
All products		71			111			1,031		1,223
Proprietary products margin as a percentage of product line margin (%)
Crop nutrients		12			16			28		21
Crop protection products		10			14			30		35
Seed		(9	)		(7	)		39		39
Merchandise		6			11			6		7
All products		8			11			23		24
Crop nutrients sales volumes (tonnes – thousands)
North America		2,073			1,819			8,985		8,106
International		790			675			3,647		3,407
Total		2,863			2,494			12,632		11,513
Crop nutrients selling price per tonne
North America		620			942			697		916
International		661			896			581		774
Total		631			930			663		874
Crop nutrients gross margin per tonne
North America		118			151			127		182
International		127			108			65		86
Total		120			139			109		153
Financial performance measures							2023		2022
Retail adjusted EBITDA margin (%) 1, 2								7		11
Retail adjusted EBITDA per US selling location (thousands of US dollars) 1, 2, 3								1,394		1,923
Retail adjusted average working capital to sales (%) 1, 4								19		17
Retail adjusted average working capital to sales excluding Nutrien Financial (%) 1, 4								1		2
Nutrien Financial adjusted net interest margin (%) 1, 4								5.2		6.8
Retail cash operating coverage ratio (%) 1, 4								68		55
1  Rolling four quarters ended December 31, 2023 and 2022.
2  These are supplementary financial measures. See the “Other Financial Measures” section.
3  Excluding acquisitions.
4  These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

Nutrien Financial	As at December 31, 2023															As at December 31, 2022
(millions of US dollars)	Current		<31 Days Past Due		31–90 Days Past Due		>90 Days Past Due		Gross Receivables		Allowance 1			Net Receivables		Net Receivables
North America		1,736		327		89		94		2,246		(40	)		2,206		2,007
International		560		56		22		59		697		(10	)		687		662
Nutrien Financial receivables		2,296		383		111		153		2,943		(50	)		2,893		2,669
1  Bad debt expense on the above receivables for the twelve months ended December 31, 2023 was $35 million (2022 – $10 million) in the Retail segment.

14

Selected Nitrogen Measures	Three Months Ended December 31			Twelve Months Ended December 31
		2023	2022		2023	2022
Sales volumes (tonnes – thousands)
Fertilizer 1		1,648	1,467		6,067	5,628
Industrial and feed		1,086	1,129		4,356	4,652
Net sales (millions of US dollars)
Fertilizer 1		533	901		2,450	3,726
Industrial and feed		344	687		1,380	2,878
Net selling price per tonne
Fertilizer 1		323	614		404	662
Industrial and feed		317	608		317	619
1 Certain immaterial 2022 figures have been reclassified.
Production Measures	Three Months Ended December 31			Twelve Months Ended December 31
		2023	2022		2023	2022
Potash production (Product tonnes – thousands)		3,386	2,941		12,998	13,007
Potash shutdown weeks 1		-	3		5	18
Ammonia production – total 2		1,362	1,400		5,357	5,759
Ammonia production – adjusted 2, 3		1,022	920		3,902	3,935
Ammonia operating rate (%) 3		91	83		88	90
P2O5production (P2O5 tonnes – thousands)		380	288		1,406	1,351
P2O5 operating rate (%)		89	67		83	79
1  Represents weeks of full production shutdown, including inventory adjustments and unplanned events, excluding the impact of any periods of reduced operating rates, planned routine annual maintenance shutdowns and announced workforce reductions.
2  All figures are provided on a gross production basis in thousands of product tonnes.
3  Excludes Trinidad and Joffre.

Appendix B – Non-GAAP Financial Measures

We use both International Financial Reporting Standards (“IFRS”) measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that (a) depict historical or expected future financial performance, financial position or cash flow of the Company, (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company, (c) are not disclosed in the financial statements of the Company and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

15

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and certain foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses, gain or loss on disposal of certain businesses and investments, asset retirement obligations (“ARO”) and accrued environmental costs (“ERL”) related to our non-operating sites, and loss on remitting cash from certain foreign jurisdictions (e.g., Blue Chip Swaps). In 2023, we amended our calculation of adjusted EBITDA to adjust for the asset retirement obligations and accrued environmental costs related to our non-operating sites and the loss on remitting cash from certain foreign jurisdictions. We do not consider these to be part of our day-to-day operations. There were no similar income and expense in the comparative periods.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

	Three Months Ended December 31					Twelve Months Ended December 31
(millions of US dollars)		2023		2022			2023		2022
Net earnings		176		1,118			1,282		7,687
Finance costs		213		188			793		563
Income tax (recovery) expense		(96	)	353			670		2,559
Depreciation and amortization		565		520			2,169		2,012
EBITDA 1		858		2,179			4,914		12,821
Adjustments:
Integration and restructuring related costs		20		11			49		46
Share-based compensation (recovery) expense		(7	)	(59	)		(14	)	63
Impairment (reversal of impairment) of assets		76		-			774		(780	)
ARO/ERL expense for non-operating sites		142		-			152		-
Foreign exchange (gain) loss, net of related derivatives		(14	)	(36	)		91		31
Loss on Blue Chip Swaps		-		-			92		-
Gain on disposal of investment		-		-			-		(19	)
COVID-19 related expenses ²		-		-			-		8
Adjusted EBITDA		1,075		2,095			6,058		12,170

1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

2 COVID-19 related expenses primarily consist of increased cleaning and sanitization costs, the purchase of personal protective equipment, discretionary supplemental employee costs, and costs related to construction delays from access limitations and other government restrictions.

16

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and certain foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, COVID-19 related expenses (including those recorded under finance costs), gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss on remitting cash from certain foreign jurisdictions (e.g., Blue Chip Swaps), change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations in Switzerland (“Swiss Tax Reform adjustment”) resulting in an income tax recovery from the recognition of a deferred tax asset. In 2023, we amended our calculation of adjusted net earnings and adjusted net earnings per share to adjust for the asset retirement obligations and accrued environmental costs related to our non-operating sites, the loss on remitting cash from certain foreign jurisdictions, the change in recognition of Retail – South America tax losses and deductible temporary differences and the Swiss Tax Reform adjustment. We do not consider these to be part of our day-to-day operations. There were no similar income and expense in the comparative periods. We generally apply the annual forecasted effective tax rate to our adjustments during the year, and at year-end, we apply the actual effective tax rate. Prior to December 31, 2023, we applied a specific tax rate for material adjustments. Effective December 31, 2023, we applied a tax rate specific to each adjustment.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

	Three Months Ended December 31, 2023							Twelve Months Ended December 31, 2023
(millions of US dollars, except as otherwise noted)		Increases (Decreases)		Post-Tax		Per Diluted Share			Increases (Decreases)		Post-Tax		Per Diluted Share
Net earnings attributable to equity holders of Nutrien				172		0.35					1,258		2.53
Adjustments:
Share-based compensation recovery		(7	)	(5	)	(0.01	)		(14	)	(11	)	(0.02	)
Foreign exchange (gain) loss, net of related derivatives		(14	)	(16	)	(0.03	)		91		83		0.17
Integration and restructuring related costs		20		16		0.03			49		40		0.08
Impairment of assets		76		49		0.10			774		702		1.42
ARO/ERL expense for non-operating sites		142		102		0.20			152		110		0.22
Loss on Blue Chip Swaps		-		-		-			92		92		0.18
Swiss Tax Reform adjustment		(134	)	(134	)	(0.27	)		(134	)	(134	)	(0.27	)
Change in recognition of deferred tax assets		-		-		-			66		66		0.13
Adjusted net earnings				184		0.37					2,206		4.44

	Three Months Ended December 31, 2022							Twelve Months Ended December 31, 2022
(millions of US dollars, except as otherwise noted)		Increases (Decreases)		Post-Tax		Per Diluted Share			Increases (Decreases)		Post-Tax		Per Diluted Share
Net earnings attributable to equity holders of Nutrien				1,112		2.15					7,660		14.18
Adjustments:
Share-based compensation (recovery) expense		(59	)	(45	)	(0.09	)		63		47		0.10
Foreign exchange (gain) loss, net of related derivatives		(36	)	(27	)	(0.05	)		31		23		0.05
Integration and restructuring related costs		11		8		0.01			46		35		0.06
Reversal of impairment of assets		-		-		-			(780	)	(619	)	(1.15	)
COVID-19 related expenses		-		-		-			8		6		0.01
Gain on disposal of investment		-		-		-			(19	)	(14	)	(0.03	)
Gain on settlement of discontinued hedge accounting derivative		-		-		-			(18	)	(14	)	(0.03	)
Adjusted net earnings				1,048		2.02					7,124		13.19

17

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

	Three Months Ended December 31					Twelve Months Ended December 31
(millions of US dollars, except as otherwise noted)		2023		2022			2023		2022
Total COGS – Potash		349		310			1,396		1,400
Change in inventory		7		38			(40	)	58
Other adjustments 1		(7	)	(12	)		(26	)	(41	)
COPM		349		336			1,330		1,417
Depreciation and amortization in COPM		(124	)	(89	)		(427	)	(406	)
Royalties in COPM		(23	)	(40	)		(100	)	(190	)
Natural gas costs and carbon taxes in COPM		(12	)	(17	)		(46	)	(62	)
Controllable cash COPM		190		190			757		759
Production tonnes (tonnes – thousands)		3,386		2,941			12,998		13,007
Potash controllable cash COPM per tonne		56		65			58		58
1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

18

Ammonia Controllable Cash COPM Per Tonne

Most directly comparable IFRS financial measure: Total manufactured COGS for the Nitrogen segment.

Definition: Total Nitrogen COGS excluding depreciation and amortization expense included in COGS, cash COGS for products other than ammonia, other adjustments, and natural gas and steam costs, divided by net ammonia production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Ammonia controllable cash COPM excludes the effects of production from other periods, the costs of natural gas and steam, and long-term investment decisions, supporting a focus on the performance of our day-to-day operations.

	Three Months Ended December 31					Twelve Months Ended December 31
(millions of US dollars, except as otherwise noted)		2023		2022			2023		2022
Total Manufactured COGS – Nitrogen 1		595		892			2,435		3,370
Total Other COGS – Nitrogen 1		76		201			393		882
Total COGS – Nitrogen		671		1,093			2,828		4,252
Depreciation and amortization in COGS		(123	)	(131	)		(474	)	(465	)
Cash COGS for products other than ammonia		(367	)	(648	)		(1,693	)	(2,560	)
Ammonia
Total cash COGS before other adjustments		181		314			661		1,227
Other adjustments 2		(76	)	(65	)		(222	)	(210	)
Total cash COPM		105		249			439		1,017
Natural gas and steam costs in COPM		(73	)	(212	)		(304	)	(855	)
Controllable cash COPM		32		37			135		162
Production tonnes (net tonnes 3 – thousands)		564		655			2,276		2,754
Ammonia controllable cash COPM per tonne		59		57			60		59
1 Certain immaterial 2022 figures have been reclassified.
2 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.
3 Ammonia tonnes available for sale, as not upgraded to other nitrogen products.

Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working

Capital to Sales Excluding Nutrien Financial

Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)		Q1 2023		Q2 2023		Q3 2023		Q4 2023		Average/Total
Current assets		13,000		11,983		10,398		10,498
Current liabilities		(8,980	)	(8,246	)	(5,228	)	(8,210	)
Working capital		4,020		3,737		5,170		2,288		3,804
Working capital from certain recent acquisitions		-		-		-		-
Adjusted working capital		4,020		3,737		5,170		2,288		3,804
Nutrien Financial working capital		(2,283	)	(4,716	)	(4,353	)	(2,893	)
Adjusted working capital excluding Nutrien Financial		1,737		(979	)	817		(605	)	243
Sales		3,422		9,128		3,490		3,502
Sales from certain recent acquisitions		-		-		-		-
Adjusted sales		3,422		9,128		3,490		3,502		19,542
Nutrien Financial revenue		(57	)	(122	)	(73	)	(70	)
Adjusted sales excluding Nutrien Financial		3,365		9,006		3,417		3,432		19,220
Adjusted average working capital to sales (%)										19
Adjusted average working capital to sales excluding Nutrien Financial (%)										1

19

	Rolling four quarters ended December 31, 2022
(millions of US dollars, except as otherwise noted)		Q1 2022		Q2 2022		Q3 2022		Q4 2022		Average/Total
Current assets		12,392		12,487		11,262		11,668
Current liabilities		(9,223	)	(9,177	)	(5,889	)	(8,708	)
Working capital		3,169		3,310		5,373		2,960		3,703
Working capital from certain recent acquisitions		-		-		-		-
Adjusted working capital		3,169		3,310		5,373		2,960		3,703
Nutrien Financial working capital		(2,274	)	(4,404	)	(3,898	)	(2,669	)
Adjusted working capital excluding Nutrien Financial		895		(1,094	)	1,475		291		392
Sales		3,861		9,422		3,980		4,087
Sales from certain recent acquisitions		-		-		-		-
Adjusted sales		3,861		9,422		3,980		4,087		21,350
Nutrien Financial revenue		(49	)	(91	)	(65	)	(62	)
Adjusted sales excluding Nutrien Financial		3,812		9,331		3,915		4,025		21,083
Adjusted average working capital to sales (%)										17
Adjusted average working capital to sales excluding Nutrien Financial (%)										2

Nutrien Financial Adjusted Net Interest Margin

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)		Q1 2023			Q2 2023			Q3 2023			Q4 2023			Total/Average
Nutrien Financial revenue		57			122			73			70
Deemed interest expense 1		(20	)		(39	)		(41	)		(36	)
Net interest		37			83			32			34			186
Average Nutrien Financial net receivables		2,283			4,716			4,353			2,893			3,561
Nutrien Financial adjusted net interest margin (%)														5.2
	Rolling four quarters ended December 31, 2022
(millions of US dollars, except as otherwise noted)	Q1 2022			Q2 2022			Q3 2022			Q4 2022			Total/Average
Nutrien Financial revenue		49			91			65			62
Deemed interest expense 1		(6	)		(12	)		(12	)		(11	)
Net interest		43			79			53			51			226
Average Nutrien Financial net receivables		2,274			4,404			3,898			2,669			3,311
Nutrien Financial adjusted net interest margin (%)														6.8
1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

20

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate free cash flow.

	Rolling four quarters ended December 31, 2023
(millions of US dollars, except as otherwise noted)	Q1 2023			Q2 2023			Q3 2023			Q4 2023			Total
Selling expenses		765			971			798			841			3,375
General and administrative expenses		50			55			57			55			217
Other expenses		15			29			37			77			158
Operating expenses		830			1,055			892			973			3,750
Depreciation and amortization in operating expenses		(179	)		(185	)		(186	)		(199	)		(749	)
Operating expenses excluding depreciation and amortization		651			870			706			774			3,001
Gross margin		615			1,931			895			989			4,430
Depreciation and amortization in cost of goods sold		2			3			3			2			10
Gross margin excluding depreciation and amortization		617			1,934			898			991			4,440
Cash operating coverage ratio (%)														68
	Rolling four quarters ended December 31, 2022
(millions of US dollars, except as otherwise noted)	Q1 2022			Q2 2022			Q3 2022			Q4 2022			Total
Selling expenses		722			1,013			821			836			3,392
General and administrative expenses		45			54			50			51			200
Other expenses (income)		(12	)		21			19			1			29
Operating expenses		755			1,088			890			888			3,621
Depreciation and amortization in operating expenses		(167	)		(171	)		(204	)		(198	)		(740	)
Operating expenses excluding depreciation and amortization		588			917			686			690			2,881
Gross margin		845			2,340			917			1,077			5,179
Depreciation and amortization in cost of goods sold		2			4			2			4			12
Gross margin excluding depreciation and amortization		847			2,344			919			1,081			5,191
Cash operating coverage ratio (%)														55

21

Appendix C – Other Financial Measures

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures if not previously provided.

Retail adjusted EBITDA margin: Retail adjusted EBITDA divided by Retail sales for the last four rolling quarters.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures excludes capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Retail adjusted EBITDA per US selling location: Calculated as total Retail US adjusted EBITDA for the last four rolling quarters, representing the organic EBITDA component, which excludes acquisitions in those quarters, divided by the number of US locations that have generated sales in the last four rolling quarters, adjusted for acquired locations in those quarters.

Cash used for dividends and share repurchases (shareholder returns): Calculated as dividends paid to Nutrien’s shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.

22

Unaudited In millions of US dollars except as otherwise noted 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

		Three Months Ended December 31					Twelve Months Ended December 31
	Note		2023		2022			2023		2022
SALES	2		5,664		7,533			29,056		37,884
Freight, transportation and distribution			260		244			974		872
Cost of goods sold			3,636		4,383			19,608		21,588
GROSS MARGIN			1,768		2,906			8,474		15,424
Selling expenses			849		844			3,397		3,414
General and administrative expenses			173		162			626		565
Provincial mining taxes			79		190			398		1,149
Share-based compensation (recovery) expense			(7	)	(59	)		(14	)	63
Impairment (reversal of impairment) of assets	3		76		-			774		(780	)
Other expenses	4		305		110			548		204
EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES			293		1,659			2,745		10,809
Finance costs			213		188			793		563
EARNINGS BEFORE INCOME TAXES			80		1,471			1,952		10,246
Income tax (recovery) expense	5		(96	)	353			670		2,559
NET EARNINGS			176		1,118			1,282		7,687
Attributable to
Equity holders of Nutrien			172		1,112			1,258		7,660
Non-controlling interest			4		6			24		27
NET EARNINGS			176		1,118			1,282		7,687
NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)
Basic			0.35		2.15			2.53		14.22
Diluted			0.35		2.15			2.53		14.18
Weighted average shares outstanding for basic EPS			494,545,000		516,810,000			496,381,000		538,475,000
Weighted average shares outstanding for diluted EPS			494,878,000		517,964,000			496,994,000		540,010,000
Condensed Consolidated Statements of Comprehensive Income
		Three Months Ended December 31					Twelve Months Ended December 31
(Net of related income taxes)			2023		2022			2023		2022
NET EARNINGS			176		1,118			1,282		7,687
Other comprehensive income (loss)
Items that will not be reclassified to net earnings:
Net actuarial (loss) gain on defined benefit plans			(14	)	22			(17	)	83
Net fair value (loss) gain on investments			(1	)	17			4		(44	)
Items that have been or may be subsequently reclassified to net earnings:
Gain (loss) on currency translation of foreign operations			103		73			89		(199	)
Other			9		7			5		(17	)
OTHER COMPREHENSIVE INCOME (LOSS)			97		119			81		(177	)
COMPREHENSIVE INCOME			273		1,237			1,363		7,510
Attributable to
Equity holders of Nutrien			268		1,230			1,338		7,484
Non-controlling interest			5		7			25		26
COMPREHENSIVE INCOME			273		1,237			1,363		7,510
(See Notes to the Condensed Consolidated Financial Statements)

23

Unaudited In millions of US dollars except as otherwise noted 

Condensed Consolidated Statements of Cash Flows

		Three Months Ended December 31				Twelve Months Ended December 31
	Note	2023		2022		2023		2022
				Note 1				Note 1
OPERATING ACTIVITIES
Net earnings		176		1,118		1,282		7,687
Adjustments for:
Depreciation and amortization		565		520		2,169		2,012
Share-based compensation (recovery) expense		(7	)	(59	)	(14	)	63
Impairment (reversal of impairment) of assets	3	76		-		774		(780	)
(Recovery of) provision for deferred income tax		(169	)	30		7		182
Net distributed (undistributed) earnings of equity-accounted investees		5		(42	)	117		(181	)
Gain on amendments to other post-retirement pension plans		-		-		(80	)	-
Loss on Blue Chip Swaps	4	-		-		92		-
Long-term income tax receivables and payables		24		72		(65	)	273
Other long-term assets, liabilities and miscellaneous		153		(29	)	277		2
Cash from operations before working capital changes		823		1,610		4,559		9,258
Changes in non-cash operating working capital:
Receivables		2,370		2,683		879		(919	)
Inventories and prepaid expenses and other current assets		(1,990	)	(1,841	)	1,376		(1,167	)
Payables and accrued charges		2,947		2,284		(1,748	)	938
CASH PROVIDED BY OPERATING ACTIVITIES		4,150		4,736		5,066		8,110
INVESTING ACTIVITIES
Capital expenditures 1		(781	)	(986	)	(2,671	)	(2,475	)
Business acquisitions, net of cash acquired		(37	)	(329	)	(153	)	(407	)
Proceeds from sales of Blue Chip Swaps, net of purchases	4	-		-		(92	)	-
Net changes in non-cash working capital		46		33		(22	)	(44	)
Other		39		60		(20	)	25
CASH USED IN INVESTING ACTIVITIES		(733	)	(1,222	)	(2,958	)	(2,901	)
FINANCING ACTIVITIES
(Repayment of) proceeds from short-term debt, net		(2,671	)	(2,338	)	(458	)	529
Proceeds from long-term debt		-		1,004		1,500		1,045
Repayment of long-term debt		(13	)	(511	)	(648	)	(561	)
Repayment of principal portion of lease liabilities		(97	)	(85	)	(375	)	(341	)
Dividends paid to Nutrien’s shareholders	6	(262	)	(251	)	(1,032	)	(1,031	)
Repurchase of common shares	6	-		(1,214	)	(1,047	)	(4,520	)
Issuance of common shares		1		-		33		168
Other		-		(17	)	(34	)	(20	)
CASH USED IN FINANCING ACTIVITIES		(3,042	)	(3,412	)	(2,061	)	(4,731	)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS		12		(24	)	(7	)	(76	)
INCREASE IN CASH AND CASH EQUIVALENTS		387		78		40		402
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD		554		823		901		499
CASH AND CASH EQUIVALENTS – END OF PERIOD		941		901		941		901
Cash and cash equivalents is composed of:
Cash		909		775		909		775
Short-term investments		32		126		32		126
		941		901		941		901
SUPPLEMENTAL CASH FLOWS INFORMATION
Interest paid		267		202		729		482
Income taxes paid		42		379		1,764		1,882
Total cash outflow for leases		128		120		501		459
1 Includes additions to property, plant and equipment, and intangible assets for the three months ended December 31, 2023 of $731 and $50 (2022 – $919 and $67), respectively, and for the twelve months ended December 31, 2023 of $2,465 and $206 (2022 – $2,253 and $222), respectively.
(See Notes to the Condensed Consolidated Financial Statements)

24

Unaudited In millions of US dollars except as otherwise noted 

Condensed Consolidated Statements of Changes in Shareholders’ Equity

										Accumulated Other Comprehensive (Loss) Income (“AOCI”)
	Number of Common Shares			Share Capital			Contributed Surplus			(Loss) Gain on Currency Translation of Foreign Operations			Other			Total AOCI			Retained Earnings			Equity Holders of Nutrien			Non- Controlling Interest			Total Equity
BALANCE – DECEMBER 31, 2021		557,492,516			15,457			149			(176	)		30			(146	)		8,192			23,652			47			23,699
Net earnings		-			-			-			-			-			-			7,660			7,660			27			7,687
Other comprehensive (loss) income		-			-			-			(198	)		22			(176	)		-			(176	)		(1	)		(177	)
Shares repurchased		(53,312,559	)		(1,487	)		(22	)		-			-			-			(2,987	)		(4,496	)		-			(4,496	)
Dividends declared		-			-			-			-			-			-			(1,019	)		(1,019	)		-			(1,019	)
Non-controlling interest transactions		-			-			-			-			-			-			(1	)		(1	)		(28	)		(29	)
Effect of share-based compensation including issuance of common shares		3,066,148			202			(18	)		-			-			-			-			184			-			184
Transfer of net loss on cash flow hedges		-			-			-			-			14			14			-			14			-			14
Transfer of net actuarial gain on defined benefit plans		-			-			-			-			(83	)		(83	)		83			-			-			-
BALANCE – DECEMBER 31, 2022		507,246,105			14,172			109			(374	)		(17	)		(391	)		11,928			25,818			45			25,863
Net earnings		-			-			-			-			-			-			1,258			1,258			24			1,282
Other comprehensive income (loss)		-			-			-			88			(8	)		80			-			80			1			81
Shares repurchased		(13,378,189	)		(374	)		(26	)		-			-			-			(600	)		(1,000	)		-			(1,000	)
Dividends declared		-			-			-			-			-			-			(1,050	)		(1,050	)		-			(1,050	)
Non-controlling interest transactions		-			-			-			-			-			-			(2	)		(2	)		(25	)		(27	)
Effect of share-based compensation including issuance of common shares		683,814			40			-			-			-			-			-			40			-			40
Transfer of net gain on sale of investment		-			-			-			-			(14	)		(14	)		14			-			-			-
Transfer of net loss on cash flow hedges		-			-			-			-			12			12			-			12			-			12
Transfer of net actuarial loss on defined benefit plans		-			-			-			-			17			17			(17	)		-			-			-
BALANCE – DECEMBER 31, 2023		494,551,730			13,838			83			(286	)		(10	)		(296	)		11,531			25,156			45			25,201

(See Notes to the Condensed Consolidated Financial Statements)

25

Unaudited In millions of US dollars except as otherwise noted 

Condensed Consolidated Balance Sheets

			December 31			December 31
As at	Note		2023			2022
ASSETS
Current assets
Cash and cash equivalents				941			901
Receivables				5,398			6,194
Inventories				6,336			7,632
Prepaid expenses and other current assets				1,495			1,615
				14,170			16,342
Non-current assets
Property, plant and equipment				22,461			21,767
Goodwill				12,114			12,368
Intangible assets				2,217			2,297
Investments				736			843
Other assets				1,051			969
TOTAL ASSETS				52,749			54,586
LIABILITIES
Current liabilities
Short-term debt				1,815			2,142
Current portion of long-term debt				512			542
Current portion of lease liabilities				327			305
Payables and accrued charges				9,467			11,291
				12,121			14,280
Non-current liabilities
Long-term debt				8,913			8,040
Lease liabilities				999			899
Deferred income tax liabilities				3,574			3,547
Pension and other post-retirement benefit liabilities				252			319
Asset retirement obligations and accrued environmental costs				1,489			1,403
Other non-current liabilities				200			235
TOTAL LIABILITIES				27,548			28,723
SHAREHOLDERS’ EQUITY
Share capital		6		13,838			14,172
Contributed surplus				83			109
Accumulated other comprehensive loss				(296	)		(391	)
Retained earnings				11,531			11,928
Equity holders of Nutrien				25,156			25,818
Non-controlling interest				45			45
TOTAL SHAREHOLDERS’ EQUITY				25,201			25,863
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY				52,749			54,586

 (See Notes to the Condensed Consolidated Financial Statements)

26

Unaudited In millions of US dollars except as otherwise noted 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Twelve Months Ended December 31, 2023

NOTE 1 BASIS OF PRESENTATION

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is the world’s largest provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2022 annual consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual consolidated financial statements and should be read in conjunction with our 2022 annual consolidated financial statements.

Certain immaterial 2022 figures have been reclassified in the condensed consolidated statements of cash flows. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on February 21, 2024.

NOTE 2  SEGMENT INFORMATION

The Company has four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise. Retail provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces.

27

Unaudited In millions of US dollars except as otherwise noted 

	Three Months Ended December 31, 2023
	Retail			Potash			Nitrogen		Phosphate			Corporate and Others			Eliminations			Consolidated
Sales   – third party		3,504			734			895		531			-			-			5,664
– intersegment		(2	)		129			223		84			-			(434	)		-
Sales   – total		3,502			863			1,118		615			-			(434	)		5,664
Freight, transportation and distribution		-			87			162		82			-			(71	)		260
Net sales		3,502			776			956		533			-			(363	)		5,404
Cost of goods sold		2,513			349			671		463			-			(360	)		3,636
Gross margin		989			427			285		70			-			(3	)		1,768
Selling expenses		841			3			4		1			7			(7	)		849
General and administrative expenses		55			3			10		1			104			-			173
Provincial mining taxes		-			79			-		-			-			-			79
Share-based compensation recovery		-			-			-		-			(7	)		-			(7	)
Impairment of assets		-			-			76		-			-			-			76
Other expenses (income)		77			(3	)		26		19			161			25			305
Earnings (loss) before finance costs and  income taxes		16			345			169		49			(265	)		(21	)		293
Depreciation and amortization		201			118			146		81			19			-			565
EBITDA 1		217			463			315		130			(246	)		(21	)		858
Integration and restructuring related costs		12			-			-		-			8			-			20
Share-based compensation recovery		-			-			-		-			(7	)		-			(7	)
Impairment of assets		-			-			76		-			-			-			76
ARO/ERL expense for non-operating sites 2		-			-			-		-			142			-			142
Foreign exchange gain, net of related  derivatives		-			-			-		-			(14	)		-			(14	)
Adjusted EBITDA		229			463			391		130			(117	)		(21	)		1,075
Assets – at December 31, 2023		23,056			13,571			11,466		2,438			2,818			(600	)		52,749
1  EBITDA is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization. 2  ARO/ERL refers to asset retirement obligations and accrued environmental costs.
	Three Months Ended December 31, 2022
	Retail			Potash			Nitrogen		Phosphate			Corporate and Others			Eliminations			Consolidated
Sales   – third party		4,089			1,255			1,677		512			-			-			7,533
– intersegment		(2	)		203			272		54			-			(527	)		-
Sales   – total		4,087			1,458			1,949		566			-			(527	)		7,533
Freight, transportation and distribution		-			81			157		65			-			(59	)		244
Net sales		4,087			1,377			1,792		501			-			(468	)		7,289
Cost of goods sold		3,010			310			1,093		485			-			(515	)		4,383
Gross margin		1,077			1,067			699		16			-			47			2,906
Selling expenses		836			1			6		2			5			(6	)		844
General and administrative expenses		51			3			5		4			99			-			162
Provincial mining taxes		-			190			-		-			-			-			190
Share-based compensation recovery		-			-			-		-			(59	)		-			(59	)
Other expenses (income)		1			4			2		40			67			(4	)		110
Earnings (loss) before finance costs and income taxes		189			869			686		(30	)		(112	)		57			1,659
Depreciation and amortization		202			89			155		58			16			-			520
EBITDA		391			958			841		28			(96	)		57			2,179
Integration and restructuring related costs		-			-			-		-			11			-			11
Share-based compensation recovery		-			-			-		-			(59	)		-			(59	)
Foreign exchange gain, net of related derivatives		-			-			-		-			(36	)		-			(36	)
Adjusted EBITDA		391			958			841		28			(180	)		57			2,095
Assets – at December 31, 2022		24,451			13,921			11,807		2,661			2,622			(876	)		54,586

28

Unaudited In millions of US dollars except as otherwise noted 

	Twelve Months Ended December 31, 2023
	Retail			Potash			Nitrogen			Phosphate			Corporate and Others			Eliminations			Consolidated
Sales   – third party		19,542			3,735			3,804			1,975			-			-			29,056
– intersegment		-			431			931			288			-			(1,650	)		-
Sales   – total		19,542			4,166			4,735			2,263			-			(1,650	)		29,056
Freight, transportation and distribution		-			407			528			270			-			(231	)		974
Net sales		19,542			3,759			4,207			1,993			-			(1,419	)		28,082
Cost of goods sold		15,112			1,396			2,828			1,760			-			(1,488	)		19,608
Gross margin		4,430			2,363			1,379			233			-			69			8,474
Selling expenses		3,375			12			27			6			-			(23	)		3,397
General and administrative expenses		217			13			21			11			364			-			626
Provincial mining taxes		-			398			-			-			-			-			398
Share-based compensation recovery		-			-			-			-			(14	)		-			(14	)
Impairment of assets		465			-			76			233			-			-			774
Other expenses (income)		158			(1	)		(27	)		40			348			30			548
Earnings (loss) before finance costs and income taxes		215			1,941			1,282			(57	)		(698	)		62			2,745
Depreciation and amortization		759			463			572			294			81			-			2,169
EBITDA		974			2,404			1,854			237			(617	)		62			4,914
Integration and restructuring related costs		20			-			-			-			29			-			49
Share-based compensation recovery		-			-			-			-			(14	)		-			(14	)
Impairment of assets		465			-			76			233			-			-			774
ARO/ERL expense for non-operating sites		-			-			-			-			152			-			152
Foreign exchange loss, net of related derivatives		-			-			-			-			91			-			91
Loss on Blue Chip Swaps		-			-			-			-			92			-			92
Adjusted EBITDA		1,459			2,404			1,930			470			(267	)		62			6,058
Assets – at December 31, 2023		23,056			13,571			11,466			2,438			2,818			(600	)		52,749
	Twelve Months Ended December 31, 2022
	Retail			Potash			Nitrogen			Phosphate			Corporate and Others			Eliminations			Consolidated
Sales   – third party		21,266			7,600			6,755			2,263			-			-			37,884
– intersegment		84			599			1,293			357			-			(2,333	)		-
Sales   – total		21,350			8,199			8,048			2,620			-			(2,333	)		37,884
Freight, transportation and distribution		-			300			515			243			-			(186	)		872
Net sales		21,350			7,899			7,533			2,377			-			(2,147	)		37,012
Cost of goods sold		16,171			1,400			4,252			1,884			-			(2,119	)		21,588
Gross margin		5,179			6,499			3,281			493			-			(28	)		15,424
Selling expenses		3,392			10			28			7			(1	)		(22	)		3,414
General and administrative expenses		200			9			17			13			326			-			565
Provincial mining taxes		-			1,149			-			-			-			-			1,149
Share-based compensation expense		-			-			-			-			63			-			63
Reversal of impairment of assets		-			-			-			(780	)		-			-			(780	)
Other expenses (income)		29			5			(137	)		67			227			13			204
Earnings (loss) before finance costs and income taxes		1,558			5,326			3,373			1,186			(615	)		(19	)		10,809
Depreciation and amortization		752			443			558			188			71			-			2,012
EBITDA		2,310			5,769			3,931			1,374			(544	)		(19	)		12,821
Integration and restructuring related costs		2			-			-			-			44			-			46
Share-based compensation expense		-			-			-			-			63			-			63
Reversal of impairment of assets		-			-			-			(780	)		-			-			(780	)
COVID-19 related expenses		-			-			-			-			8			-			8
Foreign exchange loss, net of related derivatives		-			-			-			-			31			-			31
Gain on disposal of investment		(19	)		-			-			-			-			-			(19	)
Adjusted EBITDA		2,293			5,769			3,931			594			(398	)		(19	)		12,170
Assets – at December 31, 2022		24,451			13,921			11,807			2,661			2,622			(876	)		54,586

For our disaggregated revenue from contracts with customers by product line or geographic location, refer to the “Segment Results” section of our news release dated February 21, 2024.

29

Unaudited In millions of US dollars except as otherwise noted 

NOTE 3 IMPAIRMENT OF ASSETS

Nitrogen

During the three and twelve months ended December 31, 2023, we identified an impairment trigger for our Trinidad cash generating unit (“CGU”), part of our Nitrogen segment, due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability. We expect improved natural gas availability in Trinidad as the development of additional natural gas fields is anticipated to add new natural gas supply starting in 2026.

			Trinidad
Recoverable amount ($)				676
Carrying amount before impairment loss ($)				752
Pre-tax impairment loss ($)				76
Impairment recorded to	Property, plant and equipment
Valuation methodology	Fair value less costs of disposal (“FVLCD”), a Level 3 measurement
Valuation technique	Five-year discounted cash flows plus a terminal value
Key assumptions
Long-term growth rate (%)				2.3
Post-tax discount rate 1 (%)				13.0
Forecasted EBITDA 2, 3 ($)				1,145

1 Discount rate used in the previous measurement in 2020 was 12.6 percent.

2 First five years of the forecast period.

3 Includes key assumptions relating to net selling price based on forecasted future natural gas contracting and availability.

The recoverable amount estimate used the following key assumptions: our forecasted EBITDA, discount rate and long-term growth rate. We used key assumptions that were based on historical data and estimates of future results from internal sources, independent third-party price benchmarks, as well as industry and market information.

The following table highlights sensitivities to the recoverable amount of our Trinidad CGU, which could result in additional impairment losses or reversals of the previously recorded losses.

Key Assumptions	Change in Assumption	Change to Recoverable Amount ($)
Long-term growth rate (%)	+ / - 1.0 percent	+ / -	55
Post-tax discount rate (%)	+ / - 1.0 percent	- / +	95
Forecasted EBITDA over forecast period ($)	+ / - 5.0 percent	+ / -	100

Goodwill Impairment Testing

Goodwill by CGU or Group of CGUs	2023			2022
Retail – North America		6,981			6,898
Retail – International 1		590			927
Potash		154			154
Nitrogen		4,389			4,389
		12,114			12,368

 1 Includes Retail – South America group of CGUs, which had goodwill of nil as at December 31, 2023 (2022 – $348).

During the three months ended June 30, 2023, we recorded an impairment of goodwill and intangible assets of $422 and $43, respectively, relating to our Retail – South America group of CGUs.

During the three and twelve months ended December 31, 2023, we performed our annual goodwill impairment testing (excluding the Retail – South America group of CGUs, which was fully impaired during the three months ended June 30, 2023) and did not identify any further impairment; however, the recoverable amount for Retail – North America group of CGUs did not substantially exceed its carrying amount. In testing for impairment of goodwill, we calculate the recoverable amount for a CGU or groups of CGUs containing goodwill. We used the FVLCD methodology based on after-tax discounted cash flows (five-year projections plus a terminal value) and incorporated assumptions an independent market participant would apply, including considerations related to climate-change initiatives. We adjusted discount rates for each CGU or group of CGUs for the risk associated with achieving our forecasts and for the country risk premium in which we expect to generate cash flows. FVLCD is a Level 3 measurement. We use our market capitalization and comparative market multiples to ensure discounted cash flow results are reasonable.

30

Unaudited In millions of US dollars except as otherwise noted 

The key assumptions with the greatest influence on the calculation of the recoverable amounts are the discount rates, terminal growth rates and forecasted EBITDA. The key forecast assumptions were based on historical data and our estimates of future results from internal sources considering industry and market information.

The Retail – North America group of CGUs recoverable amount exceeds its carrying amount by $570. Goodwill is more susceptible to impairment risk if there is an increase in the discount rate or a deterioration in business operating results or economic conditions and actual results do not meet our forecasts. A reduction in the terminal growth rate, an increase in the discount rate or a decrease in forecasted EBITDA could cause impairment in the future as shown in the table below.

2023 Annual Impairment Testing	Key Assumption Used in Impairment Model		Change Required for Carrying Amount to Equal Recoverable Amount
Terminal growth rate (%)		2.5		0.4 percent decrease
Discount rate 1 (%)		8.6		0.2 percent increase
Forecasted EBITDA over forecast period ($)		8,040		3.0 percent decrease

1 The discount rate used in the previous measurement was 8.5 percent.

The following table indicates the key assumptions used in testing the remaining groups of CGUs:

		Terminal Growth Rate (%)							Discount Rate (%)
			2023	2022						2023	2022
Retail – International 1			2.1	2.0	–	6.0				9.0	8.9	–	16.0
Potash			2.5			2.5				7.6			8.3
Nitrogen			2.3			2.0				8.3			9.3
1 The discount rates reflect the country risk premium and size for our international groups of CGUs. The terminal growth rate and discount rate ranges in 2022 included our Retail – South America group of CGUs, which are no longer included in 2023 as goodwill for this group of CGUs is nil.

NOTE 4 OTHER EXPENSES (INCOME)

	Three Months Ended   December 31						Twelve Months Ended   December 31
	2023			2022			2023			2022
Integration and restructuring related costs		20			11			49			46
Foreign exchange (gain) loss, net of related derivatives		(14	)		(36	)		91			31
Earnings of equity-accounted investees		(1	)		(47	)		(101	)		(247	)
Bad debt expense (recovery)		4			(6	)		55			12
COVID-19 related expenses		-			-			-			8
Gain on disposal of investment		-			-			-			(19	)
Project feasibility costs		33			22			86			79
Customer prepayment costs		11			7			47			42
Legal expenses		16			8			34			21
Consulting expenses		3			15			21			29
Employee special recognition award		-			61			-			61
Loss on Blue Chip Swaps		-			-			92			-
ARO/ERL expense for non-operating sites		142			-			152			-
Gain on amendments to other post-retirement pension plans		-			-			(80	)		-
Other expenses		91			75			102			141
		305			110			548			204

The Central Bank of Argentina maintains certain currency controls that limit our ability to remit cash from Argentina. Blue Chip Swaps are trade transactions that effectively allow companies to transfer US dollars out of Argentina. Through this mechanism, we incurred a loss of $92 from the purchase of securities denominated in Argentine peso and corresponding sale in US dollars during the twelve months ended December 31, 2023. The loss is a result of the significant divergence between the Blue Chip Swap market exchange rate and the official Argentinian Central Bank rate.

31

Unaudited In millions of US dollars except as otherwise noted 

NOTE 5 INCOME TAXES

	Three Months Ended   December 31					Twelve Months Ended   December 31
	2023			2022		2023		2022
Income tax (recovery) expense		(96	)		353		670		2,559
Actual effective tax rate on earnings (%)		39			23		33		25
Actual effective tax rate including discrete items (%)		(120	)		24		34		25
Discrete tax adjustments that impacted the tax rate		(127	)		22		28		30

During the three and twelve months ended December 31, 2023, we recorded a deferred tax asset of $134 related to an increase in the tax basis of our Swiss assets as a result of changes to our Switzerland tax declarations.

NOTE 6 SHARE CAPITAL

Share Repurchase Programs

On February 21, 2024, our Board of Directors approved a share repurchase program for up to five percent of our outstanding common shares. The 2024 normal course issuer bid, which is subject to the acceptance by the Toronto Stock Exchange, will expire after a one-year period, if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

Dividends Declared

We declared a dividend per share of $0.53 (2022 – $0.48) during the three months ended December 31, 2023, payable on January 12, 2024 to shareholders of record on December 29, 2023.

On February 21, 2024, our Board of Directors declared and increased our quarterly dividend to $0.54 per share payable on April 11, 2024, to shareholders of record on March 28, 2024. The total estimated dividend to be paid is $265.

NOTE 7 RELATED PARTY TRANSACTIONS

We sell potash outside Canada and the United States exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. Sales to Canpotex for the three months ended December 31, 2023 were $404 (2022 – $841) and the twelve months ended December 31, 2023 were $2,076 (2022 – $5,414). Purchases from Canpotex for the three months ended December 31, 2023 were $32 (2022 – $24) and the twelve months ended December 31, 2023 were $92 (2022 – $415).

As at	December 31, 2023		December 31, 2022
Receivables from Canpotex		162		866
Payables to Canpotex		64		203

32